HUTCHMED (China) (HCM) Common Equity (2014 - 2026)
HUTCHMED (China) (HCM) posted quarterly Common Equity of $1.3 billion for Q2 2026, up 2.58% year-over-year from $1.2 billion in Q2 2025, and up 692.1% quarter-over-quarter from $159.2 million in Q4 2025.
HUTCHMED (China) (HCM) Common Equity (2014 - 2026) Analysis & Trends
HUTCHMED (China) (HCM) has reported Common Equity for 13 consecutive years, with $1.3 billion the latest figure, recorded in Q2 2026.
- In Q2 2026, Common Equity rose 2.58% year-over-year to $1.3 billion; the TTM figure through Jun 2026 stood at $1.3 billion (up 2.58% YoY), while the FY2025 annual figure was $159.2 million, up 63.43% from the prior year.
- Common Equity rose to $1.3 billion in Q2 2026 per HCM's latest filing, from $159.2 million in the prior quarter.
- Across five years, Common Equity topped out at $93.5 billion in Q4 2023 and bottomed at $78.0 million in Q4 2022.
- Historically, Common Equity has averaged $11.0 billion across 5 years, with a median of $800.0 million in 2023.
- Annual changes were most pronounced in 2023 — Common Equity soared 119722.09% — and 2024, when it plunged 99.9%.
- HUTCHMED (China)'s Common Equity stood at $78.0 million in 2022, then jumped by 119722.09% to $93.5 billion in 2023, then slumped by 99.9% to $97.8 million in 2024, then surged by 62.83% to $159.2 million in 2025, then surged by 692.1% to $1.3 billion in 2026.
- Business Quant data shows HCM's Common Equity at $1.3 billion in Q2 2026, $159.2 million in Q4 2025, and $1.2 billion in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 22.06 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 7.76 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 3.15 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 47.42 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 6.40 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 14.26 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 3.69 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 6.59 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 4.05 Bn |
| 10 | HUTCHMED (China) | 2.18 Bn | 2.18 Bn | - | 1.27 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.26 Bn |
| Dec 31, 2025 | 159.17 Mn |
| Jun 30, 2025 | 1.23 Bn |
| Dec 31, 2024 | 97.75 Mn |
| Jun 30, 2024 | 752.02 Mn |
| Dec 31, 2023 | 93.50 Bn |
| Jun 30, 2023 | 800.02 Mn |
| Dec 31, 2022 | 78.03 Mn |
| Jun 30, 2022 | 851.85 Mn |
| Dec 31, 2021 | 126.69 Mn |
| Jun 30, 2021 | 1.01 Bn |
| Mar 31, 2021 | 428.27 Mn |
| Dec 31, 2020 | 152.71 Mn |
| Jun 30, 2020 | 367.05 Mn |
| Dec 31, 2019 | 312.90 Mn |
| Sep 30, 2019 | 337.79 Mn |
| Jun 30, 2019 | 373.04 Mn |
| Mar 31, 2019 | 400.36 Mn |
| Dec 31, 2018 | 412.26 Mn |
| Sep 30, 2018 | 424.70 Mn |